Skip to content

A prospective, multicenter, single-group objective clinical trial to evaluate the safety and efficacy of a single-use annulus fibrosus suture device for closure of the annulus fibrosus incision after nucleus pulposus resection

A prospective, multicenter, single-group objective clinical trial to evaluate the safety and efficacy of a single-use annulus fibrosus suture device for closure of the annulus fibrosus incision after nucleus pulposus resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090179
Enrollment
Unknown
Registered
2024-09-25
Start date
2024-09-28
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with intervertebral disc herniation were sutured with annulus fibrosus incision after nucleus pulposus removal

Interventions

Disposable fibrous ring sutures:Use a disposable annulus suture device for annulus suture

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age =18 years old, gender unlimited; 2) Meet the diagnosis of lumbar disc herniation (refer to the Guidelines for Diagnosis and Treatment of Lumbar disc herniation), and expect to undergo single-level disc nucleus pulposus extraction; 3) The history of lumbar disc herniation is more than 6 weeks, and systematic conservative treatment is ineffective: 4)ODI index =20 points; 5) In the VAS score of bilateral lower limbs, at least one side was =4 points; 6) The score of the three evaluation indicators according to the modified Pfirrman grade, age and disc height is no more than 7 points (see Annex 1 for the criteria); 7) Voluntarily participate and sign informed consent; 8) Be able to communicate well with research doctors, have good compliance, and can follow the requirements of clinical research.

Exclusion criteria

Exclusion criteria: 1) Laboratory examination (blood routine examination, blood biochemistry, coagulation function and blood pregnancy, etc.), imaging examination (MRI) and vital signs examination have abnormal results with clinical significance, and the researchers believe that they are not suitable for inclusion; 2) Active local or systemic infection; 3) Patients with lumbar tumors and/or spinal malformations; 4) Imaging showed calcification of the posterior longitudinal ligament; 5) A history of serious diseases of important organs (such as cardiovascular system, liver, lung, kidney and nervous system); 6) There are autoimmune diseases or abnormal coagulation function; 7) Previous or planned surgical procedures to fuse or stabilize the lumbar spine during the trial; 8) Intraoperative exploration of the location of the annulus fibriatus could not satisfy the requirement that the needle entry point was more than 2mm away from the margin of the annulus fibriatus; 9) Pregnant or lactating women, or those who have a pregnancy plan during the trial period; 10) Those who are participating in other clinical trials at the same time; 11) Other situations that the researcher considers inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Success rate of suture;

Secondary

MeasureTime frame
Annulus fibril cleft decreased in value;Reduced proportion of annular fibril cleft;Intraoperative blood loss;Suture time;Treatment success rate;VAS pain score (lower back, bilateral lower limbs);SF-12 rating;ODI index;Instrument defect;Product operation satisfaction;

Countries

China

Contacts

Public ContactWeihong Xu

The First Affiliated Hospital of Fujian Medical University

xuweihong816@126.com+86 138 0955 9480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026